Skip to main content

This job has expired

You will need to login before you can apply for a job.

Sr. Financial Analyst

Employer
Assertio Therapeutics, Inc.
Location
Lake Forest, IL, US
Start date
Jun 19, 2019

View more

Discipline
Administration, Finance
Required Education
Bachelors Degree
Position Type
Full time
Hotbed
BioMidwest

Job Details

We are looking for a highly motivated Senior Financial Analyst with a "can-do" attitude, analytical mind, and exceptional organizational and interpersonal skills to support our SEC Reporting and Technical Accounting team. This attentive professional will have an eye for detail and an enthusiasm for working cross-functionally with all areas of the company. A willingness to be mentored and learn all aspects of the business will be essential for success in the role.

Responsibilities

Essential Job Function
  • Assist in preparation of quarterly 10-Qs, annual 10-K and other SEC filings
  • Compile, organize and maintain support for financial data included in SEC filings
  • Perform research and analysis of new accounting standards and other technical accounting issues; assist in the implementation of new standards as needed
  • Initiate the disclosure checklist process each quarter
  • Assist in the preparation of Board of Director's Audit Committee presentations.
  • Assist, as needed, with Investor Relations activities
  • Assist with the accounting of equity related transactions
  • Work closely with and support auditors in the quarterly reviews and annual audit
  • Take ownership in controls related to the SEC Reporting process
  • Identify and implement process improvements in the SEC Reporting processes
  • Complete special projects as needed


Qualifications

Education and Experience
  • Bachelors Degree, B.S/B.A. in Accounting
  • Must be authorized to work in the U.S. on a permanent basis without sponsorship in the future
  • 2+ years in public accounting or 3+ years of experience in corporate accounting at a public company (SEC experience preferred)

Skills and Abilities
  • Established understanding of financial statements and concepts underlying recording, classifying, and analyzing financial transactions in US GAAP
  • Highly detail oriented, and strong organizational skills
  • Proactive and motivated self-starter
  • Intermediate Excel skills and generally savvy in utilizing/learning various software products
  • Ability to work cooperatively and collaboratively with all levels of employees
  • Proven success in meeting assigned deadlines


Assertio Therapeutics is committed to creating a diverse environment and is proud to be an equal opportunity employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, gender, gender identity, national origin, genetics, disability, age, sexual orientation or veteran status.

Company

Assertio reflects an aspirational mindset that is forward thinking, energetic, and entrepreneurial in spirit. The Assertio mission of advancing patient care is reflected in our three-pillar strategy:

Maintain
Grow
Build

Maintain

In December 2017, the Company announced the signing of a definitive Commercialization Agreement with Collegium Pharmaceutical under which Collegium will commercialize the NUCYNTA pain franchise and Assertio will receive a royalty rate on all NUCYNTA revenues based on certain net sales thresholds.

Our long-term strategy is to continue to identify, license, develop and market distinctive products that offer enhanced therapeutic options for patients in need—all while maintaining the highest ethical standards in all our business practices.

We have developed and are licensing Acuform® technology, a patented oral delivery technology that allows for targeted, extended release of compounds into the upper GI tract. Acuform is currently utilized in four marketed products, including NUCYNTA ER and Gralise. To date, we’ve also licensed Acuform to six partners

Grow

We currently market three FDA-approved products for various neurological conditions.

Build

We have created a new specialty products business unit, with the objective of assembling a portfolio of specialty/orphan drugs that address the unmet needs of patients, physicians and payers. Our initial focus is the development of Cosyntropin (synthetic ACTH depot), a unique, late-stage product that, upon approval, will provide U.S. patients, physicians and payers with an alternative option.

NASDAQ: ASRT

Company info
Website
Phone
224-419-7106
Location
100 South Saunders Road, Suite 300
Lake Forest
Illinois
60045
US

Get job alerts

Create a job alert and receive personalized job recommendations straight to your inbox.

Create alert